InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Ordentlich Peter, Directeur Scientifique. Officer active across 1 company, notably Syndax Pharmaceuticals Inc. In total, 2 reports have been recorded. History available since 31 January 2022. The latest transaction was disclosed on 31 January 2022 (J). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
1,412 shares@ US$12.390.0009% mcap50.0% of flowCommon StockSEC:0001562180-22-001079:0
1,412 shares@ US$12.390.0009% mcap100.0% of flowCommon StockSEC:0001562180-22-001079
2 of 2 declarations
About Ordentlich Peter
Peter Ordentlich is the Chief Scientific Officer at Syndax Pharmaceuticals Inc. He is responsible for leading the company's research and development initiatives, ensuring innovation and advancement in pharmaceutical technologies. Peter Ordentlich plays a key role in the scientific direction of the company, contributing to its success in the biopharmaceutical field.
